首页 | 本学科首页   官方微博 | 高级检索  
     

膀胱移行细胞癌中VEGF、bFGF及其受体的表达和临床意义
引用本文:沈阳,周齐军,王洪斌,裔寿东. 膀胱移行细胞癌中VEGF、bFGF及其受体的表达和临床意义[J]. 实用癌症杂志, 2001, 16(3): 231-234
作者姓名:沈阳  周齐军  王洪斌  裔寿东
作者单位:223002,江苏省淮阴市第二人民医院
摘    要:目的 探讨VEGF、bFGF及其受体在膀胱移行细胞癌中的表达和临床意义。方法 应用免疫组织化学SABC法研究65例膀胱浅表性与浸润性移行细胞癌VEGF及其受体flk,flt,bFGF及其受体flg的表达。结果 浸润性癌组VEGF及其受体、bFGF及其受体的表达显著高于非浸润性癌组(P<0.01)。浅表性癌组中5例复发病例5项指标均呈阳性或强阳性表达。结论 5项指标的共同表达与癌组织浸润能力密切相关。浅表性膀胱移行细胞癌中VEGF及其受体、bFGF及其受体的共同表达或高表达可作为判断肿瘤早期浸润及复发倾向的参考指标。

关 键 词:血管内皮生长因子 碱性成纤维生长因子 膀胱癌 膀胱移行细胞癌 受体 表达
文章编号:1001-5930(2001)03-0231-02

Expression and Clinical Significance of VEGF, bFGF and Their Receptor in Bladder Transition Cell Carcinoma
SHEN Yang,ZHOU Qi jun,WANG Hong bin,et al.. Expression and Clinical Significance of VEGF, bFGF and Their Receptor in Bladder Transition Cell Carcinoma[J]. The Practical Journal of Cancer, 2001, 16(3): 231-234
Authors:SHEN Yang  ZHOU Qi jun  WANG Hong bin  et al.
Affiliation:SHEN Yang,ZHOU Qi jun,WANG Hong bin,et al. Huaiyin Second People's Hospital,Huaiyin,223002
Abstract:Objective To study the expression and clinical significance of VEGF,bFGF and their receptors in bladder transition cell carcinoma.Methods Immunohistochemical method(SABC) was used to study the expression of VEGF and receptor(flk,flt),bFGF and receptor(flg) in 65 cases of superficial and infiltrative bladder transitional cell carcinoma.Results The expressions of VEGF and its receptor,bFGF and its receptor in infiltrative group were markedly more than in non infiltrative group( P <0.01).5 indexes in 5 recurrent cases of superficial group were positive and strong positive.Conclusion The common expression of 5 indexes is closely related to infitrative ability of carcinoma tissues.The common expression or high expression of superficial bladder transition cell carcinoma could be as an indicator of judging early tumor infiltration and recurrence.
Keywords:Vascular endothelial gorwthefactor(VEGF)  Basic fibroblast growth factor(bFGF)  Bladder carcinoma
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号